Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Место препаратов, влияющих на микробиоту кишечника, в современной медицине
Место препаратов, влияющих на микробиоту кишечника, в современной медицине
Ушкалова Е.А., Зырянов С.К. Место препаратов, влияющих на микробиоту кишечника, в современной медицине. Педиатрия (Прил. к журн. Consilium Medicum). 2017; 2: 37–42.
________________________________________________
Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Аннотация
В статье излагаются современные взгляды на ассоциацию организма человека с микроорганизмами – эукариотами, бактериями, археями и вирусами. Также приводятся данные о роли этой ассоциации в поддержании здоровья и развитии заболеваний. Применение пробиотиков – один из вариантов нормализации микрофлоры и поддержания здоровья. Приводятся результаты исследований с применением пробиотиков, содержащих разные штаммы микроорганизмов в разнообразных клинических ситуациях. Сопоставляются показания к применению пребиотиков, метабиотиков и пробиотиков.
Ключевые слова: пробиотики, пребиотики, метабиотики, микробиота.
Key words: probiotics, prebiotics, metabiotics, microbiota.
Ключевые слова: пробиотики, пребиотики, метабиотики, микробиота.
________________________________________________
Key words: probiotics, prebiotics, metabiotics, microbiota.
Полный текст
Список литературы
1. Shenderov BA. Metabiotics: novel idea or natural development of probiotic conception. Microb Ecol Health Dis 2013; 24.
2. Holmes E, Li JV, Athanasiou T et al. Understanding the role of gut microbiome-host metabolic signal disruption in health and disease. Trends Micobiol 2011; 19: 349–59.
3. Pflughoeft KJ, Versalovich J. Human microbiome in health and disease. Ann Rev Pathol Mech Dis 2012; 7: 99–122.
4. Zapata HJ, Quagliarello VJ. The microbiota and microbiome in aging: potential implications in health and age-related diseases. J Am Geriatr Soc 2015; 63 (4): 776–81.
5. Prakash S, Rodes L, Coussa-Charley M, Tomaro-Duchesneau C. Gut microbiota: next frontier in understanding human health and development of biotherapeutics. Biologics 2011; 5: 71–86.
6. Ianiro G, Bibbò S, Gasbarrini A, Cammarota G. Therapeutic modulation of gut microbiota: current clinical applications and future perspectives. Curr Drug Targets 2014; 15 (8): 762–70.
7. Sanders ME, Gibson G, Gill HS et al. Probiotics: their potential to impact human health. CAST Issue Paper 2007: 36.
8. Hempel S, Newberry SJ, Maher AR et al. Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis. JAMA 2012; 307 (18): 1959–69.
9. Floch MH, Walker WA, Sanders M et al. Recommendations for Probiotic Use – 2015 Update: Proceedings and Consensus Opini on. J Clin Gastroenterol 2015; 49 (Suppl.) 1: S69–73.
10. Cruchet S, Furnes R, Maruy A et al. The use of probiotics in pediatric gastroenterology: a review of the literature and recommendations by latin-american experts. Paediatr Drugs 2015; 17 (3): 199–216.
11. Hudson LE, Anderson SE, Corbett AH, Lamb TJ. Gleaning Insights from Fecal Microbiota Transplantation and Probiotic Studies for the Rational Design of Combination Microbial Therapies. Clin Microbiol Rev 2017; 30 (1): 191–231.
12. Singhi SC, Kumar S. Probiotics in critically ill children. F1000Res 2016; 5. pii: F1000 Faculty Rev-407.
13. Timmerman HM, Koning G, Mulder L et al. Monostrain, multistrain and multispecies probiotics-A comparison of functionality and efficacy. Int J Food Microbiol 2004; 96 (3): 219–33.
14. Hell M, Bernhofer C, Stalzer P et al. Probiotics in Clostridium difficile infection: reviewing the need for a multistrain probiotic. Benef Microbes 2013; 4 (1): 39–51.
15. Goldberg EJ, Bhalodia S, Jacob S et al. Clostridium difficile infection: A brief update on emerging therapies. Am J Health Syst Pharm 2015; 72 (12): 1007–12.
16. Downard CD, Renaud E, St Peter SD et al. Treatment of necrotizing enterocolitis: an American Pediatric Surgical Association Outcomes and Clinical Trials Committee systematic review. J Pediatr Surg 2012; 47 (11): 2111–22.
17. Wenus C et al. Prevention of antibiotic-associated diarrhoea by a fermented probiotic milk drink. Eur J Clin Nutr 2008; 62: 299–301.
18. Chatterjee S et al. Randomised placebo-controlled double blind multicentric trial on efficacy and safety of Lactobacillus acidophilus LA-5® and Bifidobacterium BB-12® for prevention of antibiotic-associated diarrhoea. JAPI 2013; 61: 708–12.
19. Saavedra JM et al. Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding of rotavirus. Lancet 1994; 344: 1046–9.
20. Манкевич Р.Н. и др. Опыт применения «Линекс Форте» у детей с ротавирусной инфекцией. Материалы XXIII Международного конгресса детских гастроэнтерологов России и стран СНГ. 2016; с. 245–6. / Mankevich R.N. i dr. Opyt primeneniia «Lineks Forte» u detei s rotavirusnoi infektsiei. Materialy XXIII Mezhdunarodnogo kongressa detskikh gastroenterologov Rossii i stran SNG. 2016; s. 245–6. [in Russian]
21. Kajander K et al. Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota. Aliment Pharmacol Ther 2008; 27 (1): 48–57.
22. Wang KY, Li SN, Liu CS et al. Effects of ingesting Lactobacillus- and Bifidobacterium-containing yogurt in subjects with colonized Helicobacter pylori. Am J Clin Nutr 2004; 80: 737–41.
23. Chatterjee S, Kar P, Das T et al. Randomised placebo-controlled double blind multicentric trial on efficacy and safety of Lactobacillus acidophilus LA-5 and Bifidobacterium BB-12 for prevention of antibiotic-associated diarrhoea. J Assoc Physicians India 2013; 61 (10): 708–12.
24. De Vrese M, Kristen H, Rautenberg P et al. Probiotic lactobacilli and bifidobacteria in a fermented milk product with added fruit preparation reduce antibiotic associated diarrhea and Helicobacter pylori activity. J Dairy Res 2011; 78 (4): 396–403.
25. Fukushima Y, Kawata Y, Hara H et al. Effect of a probiotic formula on intestinal immunoglobulin A production in healthy children. Int J Food Microbiol 1998; 42 (1–2): 39–44.
26. Eskesen D et al. Effect of the probiotic strain Bifidobacterium animalis subsp. lactis, BB-12, on defecation frequency in healthy subjects with low defecation frequency and abdominal discomfort: a randomised, double-blind, placebo-controlled, parallel-group trial. Br J Nutr 2015; 114 (10): 1638–46.
27. Guarner F, Khan AG, Garisch J et al. World Gastroenterology Organisation Global Guidelines: probiotics and prebiotics October 2011. J Clin Gastroenterol 2012; 46 (6): 468–81.
28. Bindels LB, Delzenne NM, Cani PD, Walter J. Towards a more comprehensive concept for prebiotics. Nat Rev Gastroenterol Hepatol 2015; 12 (5): 303–10.
29. Valcheva R, Dieleman LA. Prebiotics: Definition and protective mechanisms. Best Pract Res Clin Gastroenterol 2016; 30 (1): 27–37.
30. Sanders ME, Lenoir-Wijnkoop I, Salminen S et al. Probiotics and prebiotics: prospects for public health and nutritional recommendations. Ann N Y Acad Sci 2014; 1309: 19–29.
31. Quigley EM. Prebiotics and probiotics: their role in the management of gastrointestinal disorders in adults. Nutr Clin Pract 2012; 27 (2): 195–200.
32. Huffnagle GB, Wernick S. The Probiotics Revolution: The definitive guide to safe, natural health solutions using probiotic and prebiotic foods and supplements. NY: Bantam Books, 2007.
33. Плоскирева А.А., Горелов А.В. Место метаболитных пробиотиков в практике клинициста. РМЖ. 2014; 22 (3): 232–6. / Ploskireva A.A., Gorelov A.V. Mesto metabolitnykh probiotikov v praktike klinitsista. RMZh. 2014; 22 (3): 232–6. [in Russian]
34. Плоскирева А.А. Метаболитная терапия нарушений микробиоценозов различных биотопов организма человека. Лечащий врач. 2016; 6: 21–4. / Ploskireva A.A. Metabolitnaia terapiia narushenii mikrobiotsenozov razlichnykh biotopov organizma cheloveka. Lechashchii vrach. 2016; 6: 21–4. [in Russian]
35. Demidov DA, Demidova TI, Nechaev AP et al. Combined pectin containing drugs in the treatment of intestinal insufficiency syndrome. Eksp Klin Gastroenterol 2012; 2: 60–6.
2. Holmes E, Li JV, Athanasiou T et al. Understanding the role of gut microbiome-host metabolic signal disruption in health and disease. Trends Micobiol 2011; 19: 349–59.
3. Pflughoeft KJ, Versalovich J. Human microbiome in health and disease. Ann Rev Pathol Mech Dis 2012; 7: 99–122.
4. Zapata HJ, Quagliarello VJ. The microbiota and microbiome in aging: potential implications in health and age-related diseases. J Am Geriatr Soc 2015; 63 (4): 776–81.
5. Prakash S, Rodes L, Coussa-Charley M, Tomaro-Duchesneau C. Gut microbiota: next frontier in understanding human health and development of biotherapeutics. Biologics 2011; 5: 71–86.
6. Ianiro G, Bibbò S, Gasbarrini A, Cammarota G. Therapeutic modulation of gut microbiota: current clinical applications and future perspectives. Curr Drug Targets 2014; 15 (8): 762–70.
7. Sanders ME, Gibson G, Gill HS et al. Probiotics: their potential to impact human health. CAST Issue Paper 2007: 36.
8. Hempel S, Newberry SJ, Maher AR et al. Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis. JAMA 2012; 307 (18): 1959–69.
9. Floch MH, Walker WA, Sanders M et al. Recommendations for Probiotic Use – 2015 Update: Proceedings and Consensus Opini on. J Clin Gastroenterol 2015; 49 (Suppl.) 1: S69–73.
10. Cruchet S, Furnes R, Maruy A et al. The use of probiotics in pediatric gastroenterology: a review of the literature and recommendations by latin-american experts. Paediatr Drugs 2015; 17 (3): 199–216.
11. Hudson LE, Anderson SE, Corbett AH, Lamb TJ. Gleaning Insights from Fecal Microbiota Transplantation and Probiotic Studies for the Rational Design of Combination Microbial Therapies. Clin Microbiol Rev 2017; 30 (1): 191–231.
12. Singhi SC, Kumar S. Probiotics in critically ill children. F1000Res 2016; 5. pii: F1000 Faculty Rev-407.
13. Timmerman HM, Koning G, Mulder L et al. Monostrain, multistrain and multispecies probiotics-A comparison of functionality and efficacy. Int J Food Microbiol 2004; 96 (3): 219–33.
14. Hell M, Bernhofer C, Stalzer P et al. Probiotics in Clostridium difficile infection: reviewing the need for a multistrain probiotic. Benef Microbes 2013; 4 (1): 39–51.
15. Goldberg EJ, Bhalodia S, Jacob S et al. Clostridium difficile infection: A brief update on emerging therapies. Am J Health Syst Pharm 2015; 72 (12): 1007–12.
16. Downard CD, Renaud E, St Peter SD et al. Treatment of necrotizing enterocolitis: an American Pediatric Surgical Association Outcomes and Clinical Trials Committee systematic review. J Pediatr Surg 2012; 47 (11): 2111–22.
17. Wenus C et al. Prevention of antibiotic-associated diarrhoea by a fermented probiotic milk drink. Eur J Clin Nutr 2008; 62: 299–301.
18. Chatterjee S et al. Randomised placebo-controlled double blind multicentric trial on efficacy and safety of Lactobacillus acidophilus LA-5® and Bifidobacterium BB-12® for prevention of antibiotic-associated diarrhoea. JAPI 2013; 61: 708–12.
19. Saavedra JM et al. Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding of rotavirus. Lancet 1994; 344: 1046–9.
20. Mankevich R.N. i dr. Opyt primeneniia «Lineks Forte» u detei s rotavirusnoi infektsiei. Materialy XXIII Mezhdunarodnogo kongressa detskikh gastroenterologov Rossii i stran SNG. 2016; s. 245–6. [in Russian]
21. Kajander K et al. Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota. Aliment Pharmacol Ther 2008; 27 (1): 48–57.
22. Wang KY, Li SN, Liu CS et al. Effects of ingesting Lactobacillus- and Bifidobacterium-containing yogurt in subjects with colonized Helicobacter pylori. Am J Clin Nutr 2004; 80: 737–41.
23. Chatterjee S, Kar P, Das T et al. Randomised placebo-controlled double blind multicentric trial on efficacy and safety of Lactobacillus acidophilus LA-5 and Bifidobacterium BB-12 for prevention of antibiotic-associated diarrhoea. J Assoc Physicians India 2013; 61 (10): 708–12.
24. De Vrese M, Kristen H, Rautenberg P et al. Probiotic lactobacilli and bifidobacteria in a fermented milk product with added fruit preparation reduce antibiotic associated diarrhea and Helicobacter pylori activity. J Dairy Res 2011; 78 (4): 396–403.
25. Fukushima Y, Kawata Y, Hara H et al. Effect of a probiotic formula on intestinal immunoglobulin A production in healthy children. Int J Food Microbiol 1998; 42 (1–2): 39–44.
26. Eskesen D et al. Effect of the probiotic strain Bifidobacterium animalis subsp. lactis, BB-12, on defecation frequency in healthy subjects with low defecation frequency and abdominal discomfort: a randomised, double-blind, placebo-controlled, parallel-group trial. Br J Nutr 2015; 114 (10): 1638–46.
27. Guarner F, Khan AG, Garisch J et al. World Gastroenterology Organisation Global Guidelines: probiotics and prebiotics October 2011. J Clin Gastroenterol 2012; 46 (6): 468–81.
28. Bindels LB, Delzenne NM, Cani PD, Walter J. Towards a more comprehensive concept for prebiotics. Nat Rev Gastroenterol Hepatol 2015; 12 (5): 303–10.
29. Valcheva R, Dieleman LA. Prebiotics: Definition and protective mechanisms. Best Pract Res Clin Gastroenterol 2016; 30 (1): 27–37.
30. Sanders ME, Lenoir-Wijnkoop I, Salminen S et al. Probiotics and prebiotics: prospects for public health and nutritional recommendations. Ann N Y Acad Sci 2014; 1309: 19–29.
31. Quigley EM. Prebiotics and probiotics: their role in the management of gastrointestinal disorders in adults. Nutr Clin Pract 2012; 27 (2): 195–200.
32. Huffnagle GB, Wernick S. The Probiotics Revolution: The definitive guide to safe, natural health solutions using probiotic and prebiotic foods and supplements. NY: Bantam Books, 2007.
33. Ploskireva A.A., Gorelov A.V. Mesto metabolitnykh probiotikov v praktike klinitsista. RMZh. 2014; 22 (3): 232–6. [in Russian]
34. Ploskireva A.A. Metabolitnaia terapiia narushenii mikrobiotsenozov razlichnykh biotopov organizma cheloveka. Lechashchii vrach. 2016; 6: 21–4. [in Russian]
35. Demidov DA, Demidova TI, Nechaev AP et al. Combined pectin containing drugs in the treatment of intestinal insufficiency syndrome. Eksp Klin Gastroenterol 2012; 2: 60–6.
2. Holmes E, Li JV, Athanasiou T et al. Understanding the role of gut microbiome-host metabolic signal disruption in health and disease. Trends Micobiol 2011; 19: 349–59.
3. Pflughoeft KJ, Versalovich J. Human microbiome in health and disease. Ann Rev Pathol Mech Dis 2012; 7: 99–122.
4. Zapata HJ, Quagliarello VJ. The microbiota and microbiome in aging: potential implications in health and age-related diseases. J Am Geriatr Soc 2015; 63 (4): 776–81.
5. Prakash S, Rodes L, Coussa-Charley M, Tomaro-Duchesneau C. Gut microbiota: next frontier in understanding human health and development of biotherapeutics. Biologics 2011; 5: 71–86.
6. Ianiro G, Bibbò S, Gasbarrini A, Cammarota G. Therapeutic modulation of gut microbiota: current clinical applications and future perspectives. Curr Drug Targets 2014; 15 (8): 762–70.
7. Sanders ME, Gibson G, Gill HS et al. Probiotics: their potential to impact human health. CAST Issue Paper 2007: 36.
8. Hempel S, Newberry SJ, Maher AR et al. Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis. JAMA 2012; 307 (18): 1959–69.
9. Floch MH, Walker WA, Sanders M et al. Recommendations for Probiotic Use – 2015 Update: Proceedings and Consensus Opini on. J Clin Gastroenterol 2015; 49 (Suppl.) 1: S69–73.
10. Cruchet S, Furnes R, Maruy A et al. The use of probiotics in pediatric gastroenterology: a review of the literature and recommendations by latin-american experts. Paediatr Drugs 2015; 17 (3): 199–216.
11. Hudson LE, Anderson SE, Corbett AH, Lamb TJ. Gleaning Insights from Fecal Microbiota Transplantation and Probiotic Studies for the Rational Design of Combination Microbial Therapies. Clin Microbiol Rev 2017; 30 (1): 191–231.
12. Singhi SC, Kumar S. Probiotics in critically ill children. F1000Res 2016; 5. pii: F1000 Faculty Rev-407.
13. Timmerman HM, Koning G, Mulder L et al. Monostrain, multistrain and multispecies probiotics-A comparison of functionality and efficacy. Int J Food Microbiol 2004; 96 (3): 219–33.
14. Hell M, Bernhofer C, Stalzer P et al. Probiotics in Clostridium difficile infection: reviewing the need for a multistrain probiotic. Benef Microbes 2013; 4 (1): 39–51.
15. Goldberg EJ, Bhalodia S, Jacob S et al. Clostridium difficile infection: A brief update on emerging therapies. Am J Health Syst Pharm 2015; 72 (12): 1007–12.
16. Downard CD, Renaud E, St Peter SD et al. Treatment of necrotizing enterocolitis: an American Pediatric Surgical Association Outcomes and Clinical Trials Committee systematic review. J Pediatr Surg 2012; 47 (11): 2111–22.
17. Wenus C et al. Prevention of antibiotic-associated diarrhoea by a fermented probiotic milk drink. Eur J Clin Nutr 2008; 62: 299–301.
18. Chatterjee S et al. Randomised placebo-controlled double blind multicentric trial on efficacy and safety of Lactobacillus acidophilus LA-5® and Bifidobacterium BB-12® for prevention of antibiotic-associated diarrhoea. JAPI 2013; 61: 708–12.
19. Saavedra JM et al. Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding of rotavirus. Lancet 1994; 344: 1046–9.
20. Манкевич Р.Н. и др. Опыт применения «Линекс Форте» у детей с ротавирусной инфекцией. Материалы XXIII Международного конгресса детских гастроэнтерологов России и стран СНГ. 2016; с. 245–6. / Mankevich R.N. i dr. Opyt primeneniia «Lineks Forte» u detei s rotavirusnoi infektsiei. Materialy XXIII Mezhdunarodnogo kongressa detskikh gastroenterologov Rossii i stran SNG. 2016; s. 245–6. [in Russian]
21. Kajander K et al. Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota. Aliment Pharmacol Ther 2008; 27 (1): 48–57.
22. Wang KY, Li SN, Liu CS et al. Effects of ingesting Lactobacillus- and Bifidobacterium-containing yogurt in subjects with colonized Helicobacter pylori. Am J Clin Nutr 2004; 80: 737–41.
23. Chatterjee S, Kar P, Das T et al. Randomised placebo-controlled double blind multicentric trial on efficacy and safety of Lactobacillus acidophilus LA-5 and Bifidobacterium BB-12 for prevention of antibiotic-associated diarrhoea. J Assoc Physicians India 2013; 61 (10): 708–12.
24. De Vrese M, Kristen H, Rautenberg P et al. Probiotic lactobacilli and bifidobacteria in a fermented milk product with added fruit preparation reduce antibiotic associated diarrhea and Helicobacter pylori activity. J Dairy Res 2011; 78 (4): 396–403.
25. Fukushima Y, Kawata Y, Hara H et al. Effect of a probiotic formula on intestinal immunoglobulin A production in healthy children. Int J Food Microbiol 1998; 42 (1–2): 39–44.
26. Eskesen D et al. Effect of the probiotic strain Bifidobacterium animalis subsp. lactis, BB-12, on defecation frequency in healthy subjects with low defecation frequency and abdominal discomfort: a randomised, double-blind, placebo-controlled, parallel-group trial. Br J Nutr 2015; 114 (10): 1638–46.
27. Guarner F, Khan AG, Garisch J et al. World Gastroenterology Organisation Global Guidelines: probiotics and prebiotics October 2011. J Clin Gastroenterol 2012; 46 (6): 468–81.
28. Bindels LB, Delzenne NM, Cani PD, Walter J. Towards a more comprehensive concept for prebiotics. Nat Rev Gastroenterol Hepatol 2015; 12 (5): 303–10.
29. Valcheva R, Dieleman LA. Prebiotics: Definition and protective mechanisms. Best Pract Res Clin Gastroenterol 2016; 30 (1): 27–37.
30. Sanders ME, Lenoir-Wijnkoop I, Salminen S et al. Probiotics and prebiotics: prospects for public health and nutritional recommendations. Ann N Y Acad Sci 2014; 1309: 19–29.
31. Quigley EM. Prebiotics and probiotics: their role in the management of gastrointestinal disorders in adults. Nutr Clin Pract 2012; 27 (2): 195–200.
32. Huffnagle GB, Wernick S. The Probiotics Revolution: The definitive guide to safe, natural health solutions using probiotic and prebiotic foods and supplements. NY: Bantam Books, 2007.
33. Плоскирева А.А., Горелов А.В. Место метаболитных пробиотиков в практике клинициста. РМЖ. 2014; 22 (3): 232–6. / Ploskireva A.A., Gorelov A.V. Mesto metabolitnykh probiotikov v praktike klinitsista. RMZh. 2014; 22 (3): 232–6. [in Russian]
34. Плоскирева А.А. Метаболитная терапия нарушений микробиоценозов различных биотопов организма человека. Лечащий врач. 2016; 6: 21–4. / Ploskireva A.A. Metabolitnaia terapiia narushenii mikrobiotsenozov razlichnykh biotopov organizma cheloveka. Lechashchii vrach. 2016; 6: 21–4. [in Russian]
35. Demidov DA, Demidova TI, Nechaev AP et al. Combined pectin containing drugs in the treatment of intestinal insufficiency syndrome. Eksp Klin Gastroenterol 2012; 2: 60–6.
________________________________________________
2. Holmes E, Li JV, Athanasiou T et al. Understanding the role of gut microbiome-host metabolic signal disruption in health and disease. Trends Micobiol 2011; 19: 349–59.
3. Pflughoeft KJ, Versalovich J. Human microbiome in health and disease. Ann Rev Pathol Mech Dis 2012; 7: 99–122.
4. Zapata HJ, Quagliarello VJ. The microbiota and microbiome in aging: potential implications in health and age-related diseases. J Am Geriatr Soc 2015; 63 (4): 776–81.
5. Prakash S, Rodes L, Coussa-Charley M, Tomaro-Duchesneau C. Gut microbiota: next frontier in understanding human health and development of biotherapeutics. Biologics 2011; 5: 71–86.
6. Ianiro G, Bibbò S, Gasbarrini A, Cammarota G. Therapeutic modulation of gut microbiota: current clinical applications and future perspectives. Curr Drug Targets 2014; 15 (8): 762–70.
7. Sanders ME, Gibson G, Gill HS et al. Probiotics: their potential to impact human health. CAST Issue Paper 2007: 36.
8. Hempel S, Newberry SJ, Maher AR et al. Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis. JAMA 2012; 307 (18): 1959–69.
9. Floch MH, Walker WA, Sanders M et al. Recommendations for Probiotic Use – 2015 Update: Proceedings and Consensus Opini on. J Clin Gastroenterol 2015; 49 (Suppl.) 1: S69–73.
10. Cruchet S, Furnes R, Maruy A et al. The use of probiotics in pediatric gastroenterology: a review of the literature and recommendations by latin-american experts. Paediatr Drugs 2015; 17 (3): 199–216.
11. Hudson LE, Anderson SE, Corbett AH, Lamb TJ. Gleaning Insights from Fecal Microbiota Transplantation and Probiotic Studies for the Rational Design of Combination Microbial Therapies. Clin Microbiol Rev 2017; 30 (1): 191–231.
12. Singhi SC, Kumar S. Probiotics in critically ill children. F1000Res 2016; 5. pii: F1000 Faculty Rev-407.
13. Timmerman HM, Koning G, Mulder L et al. Monostrain, multistrain and multispecies probiotics-A comparison of functionality and efficacy. Int J Food Microbiol 2004; 96 (3): 219–33.
14. Hell M, Bernhofer C, Stalzer P et al. Probiotics in Clostridium difficile infection: reviewing the need for a multistrain probiotic. Benef Microbes 2013; 4 (1): 39–51.
15. Goldberg EJ, Bhalodia S, Jacob S et al. Clostridium difficile infection: A brief update on emerging therapies. Am J Health Syst Pharm 2015; 72 (12): 1007–12.
16. Downard CD, Renaud E, St Peter SD et al. Treatment of necrotizing enterocolitis: an American Pediatric Surgical Association Outcomes and Clinical Trials Committee systematic review. J Pediatr Surg 2012; 47 (11): 2111–22.
17. Wenus C et al. Prevention of antibiotic-associated diarrhoea by a fermented probiotic milk drink. Eur J Clin Nutr 2008; 62: 299–301.
18. Chatterjee S et al. Randomised placebo-controlled double blind multicentric trial on efficacy and safety of Lactobacillus acidophilus LA-5® and Bifidobacterium BB-12® for prevention of antibiotic-associated diarrhoea. JAPI 2013; 61: 708–12.
19. Saavedra JM et al. Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding of rotavirus. Lancet 1994; 344: 1046–9.
20. Mankevich R.N. i dr. Opyt primeneniia «Lineks Forte» u detei s rotavirusnoi infektsiei. Materialy XXIII Mezhdunarodnogo kongressa detskikh gastroenterologov Rossii i stran SNG. 2016; s. 245–6. [in Russian]
21. Kajander K et al. Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota. Aliment Pharmacol Ther 2008; 27 (1): 48–57.
22. Wang KY, Li SN, Liu CS et al. Effects of ingesting Lactobacillus- and Bifidobacterium-containing yogurt in subjects with colonized Helicobacter pylori. Am J Clin Nutr 2004; 80: 737–41.
23. Chatterjee S, Kar P, Das T et al. Randomised placebo-controlled double blind multicentric trial on efficacy and safety of Lactobacillus acidophilus LA-5 and Bifidobacterium BB-12 for prevention of antibiotic-associated diarrhoea. J Assoc Physicians India 2013; 61 (10): 708–12.
24. De Vrese M, Kristen H, Rautenberg P et al. Probiotic lactobacilli and bifidobacteria in a fermented milk product with added fruit preparation reduce antibiotic associated diarrhea and Helicobacter pylori activity. J Dairy Res 2011; 78 (4): 396–403.
25. Fukushima Y, Kawata Y, Hara H et al. Effect of a probiotic formula on intestinal immunoglobulin A production in healthy children. Int J Food Microbiol 1998; 42 (1–2): 39–44.
26. Eskesen D et al. Effect of the probiotic strain Bifidobacterium animalis subsp. lactis, BB-12, on defecation frequency in healthy subjects with low defecation frequency and abdominal discomfort: a randomised, double-blind, placebo-controlled, parallel-group trial. Br J Nutr 2015; 114 (10): 1638–46.
27. Guarner F, Khan AG, Garisch J et al. World Gastroenterology Organisation Global Guidelines: probiotics and prebiotics October 2011. J Clin Gastroenterol 2012; 46 (6): 468–81.
28. Bindels LB, Delzenne NM, Cani PD, Walter J. Towards a more comprehensive concept for prebiotics. Nat Rev Gastroenterol Hepatol 2015; 12 (5): 303–10.
29. Valcheva R, Dieleman LA. Prebiotics: Definition and protective mechanisms. Best Pract Res Clin Gastroenterol 2016; 30 (1): 27–37.
30. Sanders ME, Lenoir-Wijnkoop I, Salminen S et al. Probiotics and prebiotics: prospects for public health and nutritional recommendations. Ann N Y Acad Sci 2014; 1309: 19–29.
31. Quigley EM. Prebiotics and probiotics: their role in the management of gastrointestinal disorders in adults. Nutr Clin Pract 2012; 27 (2): 195–200.
32. Huffnagle GB, Wernick S. The Probiotics Revolution: The definitive guide to safe, natural health solutions using probiotic and prebiotic foods and supplements. NY: Bantam Books, 2007.
33. Ploskireva A.A., Gorelov A.V. Mesto metabolitnykh probiotikov v praktike klinitsista. RMZh. 2014; 22 (3): 232–6. [in Russian]
34. Ploskireva A.A. Metabolitnaia terapiia narushenii mikrobiotsenozov razlichnykh biotopov organizma cheloveka. Lechashchii vrach. 2016; 6: 21–4. [in Russian]
35. Demidov DA, Demidova TI, Nechaev AP et al. Combined pectin containing drugs in the treatment of intestinal insufficiency syndrome. Eksp Klin Gastroenterol 2012; 2: 60–6.
Авторы
Е.А.Ушкалова*, С.К.Зырянов
ФГАОУ ВО «Российский университет дружбы народов». 117198, Россия, Москва, ул. Миклухо-Маклая, д. 6
*eushk@yandex.ru
People’s Friendship University of Russia. 117198, Russian Federation, Moscow, ul. Miklukho-Maklaia, d. 6
*eushk@yandex.ru
ФГАОУ ВО «Российский университет дружбы народов». 117198, Россия, Москва, ул. Миклухо-Маклая, д. 6
*eushk@yandex.ru
________________________________________________
People’s Friendship University of Russia. 117198, Russian Federation, Moscow, ul. Miklukho-Maklaia, d. 6
*eushk@yandex.ru
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.